Diasyst - Medication Intelligence

📍 Atlanta, United States🗓 Founded 2015👥 15 employees💰 Last funded Aug 2021
IT Services and IT Consulting🌐 diasyst.com
Website LinkedIn
Diasyst introduces the first ever Medication Intelligence solution for chronic disease management, empowering healthcare providers to make TIMELY, QUICK, SAFE, and EFFECTIVE treatment decisions. Backed by decades of research at Emory University and the VA, Diasyst gathers, computerizes, and maintains an ever-expanding knowledge base of thousands of pages of clinical guidelines, drug labels, research studies, and best practices. Through our proprietary AI, Diasyst delivers treatment recommendations to decision-makers, helping save time, increase revenues, and maximize patient outcomes.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Diasyst - Medication Intelligence?
Diasyst - Medication Intelligence has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Diasyst - Medication Intelligence last raise funding?
The most recent investment in Diasyst - Medication Intelligence recorded on gritt.io was in August 2021.
When was Diasyst - Medication Intelligence founded?
Diasyst - Medication Intelligence was founded in 2015.
What industry is Diasyst - Medication Intelligence in?
Diasyst - Medication Intelligence operates in IT Services and IT Consulting. Find similar IT Services and IT Consulting investors on gritt.io.
Where is Diasyst - Medication Intelligence based?
Diasyst - Medication Intelligence is headquartered in Atlanta, United States.